Navigation Links
Quorum Review IRB and ConsentSolutions Form Strategic Alliance

Seattle, WA (PRWEB) September 05, 2013

Quorum Review, IRB, the industry leader in central IRB services, announces a strategic alliance with Consent Solutions, a developer of internet-based multimedia systems for informed consent in the clinical trials industry. Through the alliance, Quorum Review and Consent Solutions combine and leverage their extensive experience and knowledge to provide an improved informed consent experience.

The alliance demonstrates Quorum Review’s and Consent Solutions’ commitment to enhance the research process, especially as the healthcare industry increasingly adopts electronic data systems. Working together, Quorum Review and Consent Solutions provide an intuitive and effective electronic consent option that meets industry and IRB regulations and standards.

“Quorum Review is excited to work closely with an eConsent provider who understands our industry so well,” says Cami Gearhart, JD, CEO of Quorum Review. “We believe our customers will benefit from this alliance as the healthcare and human research industry move further toward electronic data management.”

"We feel so privileged to be able to work closely with Quorum,” states Susan G. Brink, DrPH, President and CEO of Consent Solutions. “The relationship will allow us to optimize workflows and fine-tune the processes behind electronic consent from the perspective of a leading-edge IRB. Our partnership offers the potential of bringing all of the benefits of eConsent to patients and industry on a much shorter timeline."

About Quorum Review

Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.

For more information about Quorum Review, visit

About Consent Solutions

Consent Solutions has been spearheading the development and adoption of electronic consent in the clinical space since 2003. The result of extensive and ongoing research with patients, sponsors, regulatory bodies, CROs and IRBs, the Consent Solutions platform, SecureConsent, takes a patient-centered approach that is supported by video and electronic multimedia to facilitate and enhance patient comprehension. Backed by tightly controlled administrative procedures and controls, granular tracking, sophisticated version control and multi-lingual support, the SecureConsent ecosystem tackles many of the problems of paper-based consenting.

For more information about Consent Solutions, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quorum Review IRB Board Chair Appointed to SACHRP
2. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
3. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
4. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
5. FDAs Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012
6. Nonprofit Consortium Publishes Review of Skullcap Adulteration
7. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
8. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
9. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Second Quarter 2012 Financials
10. Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012
11. Alzheimers Therapeutics Reviewed by NeuroPerspective
Post Your Comments:
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
(Date:11/24/2015)... ... , ... The Academy of Model Aeronautics (AMA), led by its Executive Council, ... Grand Prix, to represent the First–Person View (FPV) racing community. , FPV racing has ... type of racing and several new model aviation pilots have joined the community because ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... today that the remaining 11,000 post-share consolidation (or ... Warrants (the "Series B Warrants") subject to the ... on November 23, 2015, which will result in ... giving effect to the issuance of such shares, ...
Breaking Biology Technology:
(Date:11/18/2015)... new scientific discoveries deepen our understanding of how cancer ... challenges in better using that knowledge to guide treatment ... children continue to survive pediatric cancer, that counseling may ... John M. Maris, M.D ., a pediatric oncologist ... --> John M. Maris, M.D ., ...
(Date:11/17/2015)... , November 17, 2015 Paris ...   --> Paris from 17 th ... DERMALOG, the biometrics innovation leader, has invented the first combined ... on the same scanning surface. Until now two different scanners ... one scanner can capture both on the same surface. ...
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
Breaking Biology News(10 mins):